key: cord-0978349-try2hugr
authors: Frishman, William H.
title: The 11th Trial of a Cardiovascular Clinical Trialist: Coronavirus 2, Part 7: COVID-19, What Next?
date: 2022-03-15
journal: Cardiol Rev
DOI: 10.1097/crd.0000000000000450
sha: 9aac3e517801e985ca3b754953b5426cf0ebaf65
doc_id: 978349
cord_uid: try2hugr

nan

During my lifetime and over 50 years of medical practice, there has been nothing that compares with the Covid-19 pandemic, and the political and economic ramifications that have come along with it. Starting with the first severe case presentation during the winter of 2020, our intensive care units were swollen beyond capacity, and now in 2022 after 1 million deaths, the acute illness appears to be under control except in high-risk, unvaccinated individuals. We may be coming to the end of masking and social distancing.

As of now, we no longer have Covid-19 wards in the hospital. Overall, despite all the challenges related to Covid-19, the United States has done relatively well in dealing with it, and is now positioned to face the upcoming health crises in the years to come.

Covid-19 vaccine effectiveness in New York State

Clinical outcomes among patients with 1-year survival following intensive care unit treatment for Covid-19

Paxlovid for the treatment of Covid-19

Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients

Comprehensive review of cardiovascular complications of coronavirus disease 2019 and beneficial treatments

Extracorporeal membrane oxygenation in patients with Covid-19

Covid-19 and cardiometabolic disease